Endosomal maturation and transport constitutes a complex trafficking system present in all cell types. Neurons have adapted their endosomal system to meet their unique and complex needs. These adaptations include repurposing existing proteins to diversify endocytosis and trafficking, as well as preferential expression of certain regulators more highly in neurons than other cell types. These neuronal regulators include the family of Neuron-Specific Gene family members (Nsg), NEEP21 (Nsg1), and P19 (Nsg2). NEEP21/Nsg1 plays a role in the trafficking of multiple receptors, including the cell adhesion molecule L1/NgCAM, the neurotransmitter receptor GluA2, and b-APP. Recently, we showed that NEEP2/Nsg1 and P19/Nsg2 are not expressed in all neuronal cell types in vitro. However, it is not known where and when NEEP21/Nsg1 and P19/Nsg2 are expressed in vivo, and whether both proteins are always coexpressed. Here, we show that NEEP21/Nsg1 and P19/Nsg2 are present in both overlapping and distinct cell populations in the hippocampus, neocortex, and cerebellum during development. NEEP21/Nsg1 and P19/Nsg2 levels are highest during embryonic development, and expression persists in the juvenile mouse brain. In particular, a subset of layer V cortical neurons retains relatively high expression of both NEEP21/Nsg1 and P19/Nsg2 at postnatal day 16 as well as in the CA1-3 regions of the hippocampus. In the cerebellum, NEEP21/Nsg1 expression becomes largely restricted to Purkinje neurons in adulthood whereas P19/Nsg2 expression strikingly disappears from the cerebellum with age. This divergent and restricted expression likely reflects differential needs for this class of trafficking regulators in different neurons during different stages of maturation.
any problems due to mistrafficking or dysregulation of recycling and degradation have particularly devastating effects.
Many proteins are highly enriched or even specifically expressed in neurons. These include proteins that fundamentally underlie neuronal synaptic function, such as neurotransmitter receptors, but also cytoskeletal proteins and proteins regulating membrane transport. One such protein is Neuron Enriched Endosomal Protein of 21kDa (NEEP21/ Nsg1), a small single-pass transmembrane protein that is highly enriched in neurons (Ohnishi, Futamura, Kamino, & Nakamura, 2010; Sab eran-Djoneidi et al., 1998) . Interestingly, NEEP21 is restricted to the somatodendritic domain (Steiner et al., 2002; Yap et al., 2008) .
NEEP21 has been shown to play a critical role in the trafficking and polarization of a variety of proteins including the axonal cell adhesion molecule L1/NgCAM, b-APP, GluA2, and neurotensin receptors (Debaigt, Hirling, Steiner, Vincent, & Mazella, 2004; Norstrom, Zhang, Tanzi, & Sisodia, 2010; Steiner et al., 2002 Steiner et al., , 2005 Yap et al., 2008) .
When NEEP21 is knocked-down in cultured neurons, L1/NgCAM becomes mislocalized to the somatodendritic region and to LAMP2-positive endosomes (Yap et al., 2008) . Missorting of cargo into LAMP2-positive endosomes in the absence of NEEP21 is also observed for neurotensin receptor and for GluA2. This dependence of correct protein trafficking on neuronal proteins specific to certain domains of the neuron highlights the complexity of the endosomal sorting machinery in neurons.
NEEP21 belongs to a family of endosomal proteins including Calcyon (Caly) and P19 (Nsg2) (Muthusamy et al., 2009) . NEEP21 and P19 show approximately 50% amino acid sequence homology to each other, and 30% to Calcyon. NEEP21 and P19 were both identified as being highly enriched in the brain and developmentally regulated (Sab eran-Djoneidi et al., 1995 , 1998 . NEEP21 has been detected in rat brains at high levels up to P14, at which point the protein levels decline greatly (Steiner et al., 2002) .
We recently showed that, surprisingly, NEEP21 and P19 were not expressed in all neurons cultured from embryonic rat hippocampus. Virtually, all CTIP2-and Satb2-positive neurons in hippocampal cultures expressed both NEEP21 and P19 robustly. In contrast, both NEEP21 and P19 were expressed at very low levels in Prox1-positive cells, which are likely derived from the dentate gyrus (Digilio et al., 2015) .
The differential expression found in cultured neurons thus prompted us to ask (a) if NEEP21 and P19 expression levels were similarly low in the dentate gyrus in vivo, (b) at what age NEEP21 and P19 expression disappeared, and (c) if NEEP21 and P19 expression profiles were always identical in vivo. In this study, we examined three brain regions: neocortex, hippocampus, and cerebellum for NEEP21 and P19 expression at several time points during development (E17), at early postnatal ages (P0, P8) and in young adults (P16). We find that NEEP21 and P19 are largely coexpressed with striking exceptions (intermediate progenitors and Purkinje neurons) where neurons selectively express only one of the two distinct endosomal proteins during development. Second, we find that expression of both proteins is broad earlier in development and restricts to small subpopulations where expression is maintained into adolescence and even adulthood.
| MATERIALS A ND METHODS

| Animals
All animal use was approved by the University of Virginia IACUC. E17 mouse brains were harvested from a timed pregnant female C57BL/ 6NCrl mice from Charles River. E18 primary rat neurons were harvested from a timed pregnant female Sprague Dawley rat from Charles River (RRID: RGD_737891). All other mice were derived from WT C57BL6 mice after IVF for knockout NEEP21 mice from KOMP (RRID: SCR_007318). The NEEP21 allele is on chromosome 5 from nucleotides 38137193-38159467. The gene was targeted by KOMP and is cleaved from the 5 0 UTR to the last exon of the coding region, exon 6, and replaced with LacZ and Neo genes. Mice aged P8 and above underwent cardiac perfusion before removal of the brain. For cardiac perfusions, mice were anesthetized with a 0.1 cc/25 gm dose of anesthetic (7 cc NaCl 1 2 cc Ketamine 100 mg/mL 1 1 cc Dexdomitor).
Phosphate-buffered saline (PBS) was automatically pumped through the heart by use of a variable flow perfusion pump (Fisher Scientific, Cat #: 13-876-2) until there was no more blood in circulation. After this, 50-100 mL 4% paraformaldehyde (PFA) was pumped through to fix the brain. The brain was removed and stored in PFA at 4 8C for at least 24 hr.
| Cryosectioning
All brains were removed from PFA and placed in 30% sucrose at 4 8C for at least 24 hr before sectioning. Brains were removed from sucrose, patted dry with a kimwipe, and placed in Tissue Freezing Media (OCT Embedding Compound, VWR Catalog Number: 25608-930). Brains were frozen in isopentane surrounded by dry ice and cut immediately at -20 8C into 20lm thick sections. Sections were placed on gelatin coated slides (1% gelatin, 0.05% chromium potassium sulfate) and kept at -80 8C.
| Immunohistochemistry
Sections were warmed to room temperature and washed with 1 X PBS 3 times for 5 min each. Antigen retrieval was performed for all antibodies by transferring slides to sodium citrate buffer (10 mM sodium citrate, pH 6.0) and microwaving until boiling. Sections were then cooled to room temperature, the sodium citrate buffer was replaced, and the sections were microwaved until boiling a second time. Sections were then rinsed three times with 1 X PBS and incubated with blocking solution (0.2% Triton X-100, 3% normal donkey serum) for 1 hour at room temperature. Sections were incubated with primary antibodies diluted in blocking buffer overnight at 4 8C. The next day, sections were washed with 1 X PBS three times and incubated with secondary antibodies for 1 hr at room temperature protected from light (secondary antibodies in antibody Table 1 ). Sections were then incubated with DAPI (4 0 ,6-Diamindino-2-Phenylindole, Dihydrochloride, ThermoFisher Scientific, Cat 3: D1306) for 10 min at room temperature. Slides were washed three times with 1 X PBS and mounted with ProLong Diamond antifade mounting media (ThermoFisher Scientific, Cat: P36970).
Antibodies used can be found in Table 1 . Imaging was performed on a Zeiss AxioZoom Observer.Z1 with Apotome 3.1 structured illumination. All images were taken with a 40 3 objective lens.
| Primary neuronal culture and transfection
Primary rat neurons were dissected and cultured from E18 rat brains as our lab has previously described (Wisco et al., 2003) . Briefly, hippocampi from E18 rat brains were dissected and dissociated, plated on coverslips, and cultured for 8-12 days. Transfections were performed as previously described by our lab (Yap et al., 2008) . The P19-sh plasmid and the random control plasmid were purchased from SABiosciences, and the constructs are expressed from the U1 promoter cassette of the hMGFP vector under the control of the CMV promoter. Briefly, 8-12 DIV neurons were transfected using Lipofectamine 2000 and incubated for 72 hr before fixation.
| Characterization of antibodies
CTIP2 is a transcription factor that is specific to developing corticospinal motor neurons in the mouse embryonic neocortex (Arlotta et al., 2005) , using an antibody to the same clone that was used to make the BioLegend antibody used in this study (RRID: AB_10896795) (Senawong et al., 2003) . The antibody recognizes 150 amino acids located at the Nterminus of the protein (Senawong et al., 2003) . The antibody was originally described as being specific in western blots showing CTIP2 coimmunoprecipitating with a binding partner, but no band in the control immunoprecipiptation (Senawong et al., 2003) . This commercial antibody is now quality tested by BioLegend through western blotting and immunofluorescence. The antibody shows characteristic staining of layer IV and layer V neurons in the neocortex as had been described in the literature (Molyneaux, Arlotta, Menezes, & Macklis, 2007) .
SatB2 is a transcription factor which marks postmitotic neurons in the upper layers of the neocortex (Britanova et al., 2008) . The commercially available antibody that we use shows this stereotypical staining.
The antibody used is commercially available through Abcam (RRID: AB_882455) and recognizes the C-terminal segment of SatB2. The antibody was shown to be specific on a western blot where it recognizes a single band for SatB2 which is not recognized upon shRNA knockdown (Asanoma et al., 2012) .
NeuN, also known as Fox-3, is a transcription factor found broadly in CNS and PNS neurons. This particular antibody shows a broad distribution of neurons (Lacoste et al., 2014) , and antibodies used against same clone commercially available from Millipore are also characteristically absent from Purkinje neurons (Kim, Adelstein, & Kawamoto, 2009 ) (RRID: AB_11205592). This antibody was shown to be specific to neurons in IHC where it does not co-localize with blood vessel markers (Lacoste et al., 2014) . The antibody is a version of the A60 clone which has been shown to be specific to neurons in IHC through lack of staining in the corpus callosum and lack of colocalization with glial subtypes (Mullen, Buck, & Smith, 1992) .
Calbindin is a calcium-binding protein present in a variety of CNS neurons. It is highly expressed in Purkinje cells, as shown through staining with the antibody available through Sigma Aldrich (Shakkottai et al., 2011) (RRID: AB_2314065) . This antibody was verified in IHC by lack of staining after preadsorption with the peptide (Celio, 1990 ).
Sox2 is a transcription factor which marks progenitor cells in the mouse neocortex. The antibody is produced by Santa Cruz against the C-terminus end of Sox2 and recognizes a single band in mouse stem cell lysates (SantaCruz, RRID: AB_2286684). This antibody was shown to be specific by western blotting where it recognizes a single band (Chew et al., 2006) . This antibody has been shown to specifically mark progenitor cells in the brain (Mathews et al., 2010) , and our staining is consistent with previous literature showing Sox2 to be expressed in the VZ (Hutton & Pevny, 2011) .
The Tbr2 chicken antibody was purchased through EMD Millipore (RRID: AB_10615604). This antibody was validated by IHC whereby it
shows identical staining to a Tbr2 Cre knock-in mouse (Vasistha et al., 2015) . Tbr2 is a transcription factor that has been shown to be expressed in intermediate progenitors but not apical progenitors/stem cells (Sessa, Mao, Hadjantonakis, Klein, & Broccoli, 2008) . In our sections, we see Tbr2 staining in the SVZ but not the VZ, consistent with this literature.
MAP2 is a microtubule bundling protein found at high levels in the somatodendritic region. MAP2 chicken antibody was purchased from
EnCor Biotechnology (RRID: AB_2138173). This antibody shows a single band on western blots from rat and mouse brain lysates (EnCor).
We have previously validated this antibody by showing colocalization with neuronal marker NeuN, and no colocalization with the glial marker GFAP in cultured neurons (Digilio et al., 2015) . Here, we again find that the antibody specifically recognizes neuronal soma and dendrites ( Fig 
| R E S U LTS
3.1 | NEEP21 and P19 antibodies are specific
Recently, antibody specificity has become a concern in publications (Baker, 2015; Prassas & Diamandis, 2014) , and we thus first validated the antibodies against NEEP21 and P19. We raised an anti-NEEP21 antibody in rabbits to the same peptide used previously in studies by Steiner et al. in 2002 Figure   1a ). To test the expression pattern of P19, we bought a commercially available rabbit monoclonal antibody to P19 from Abcam. Since no P19 knockout mouse exists, we were not able to validate the antibody on knockout sections. We were also not able to use peptide block to validate the anti-P19 antibody, since the amino acid sequence used for immunization was not disclosed by the company.
Thus, we were unable to purchase or synthesize the peptide that this antibody was raised against. Therefore, to test antibody specificity we transfected dissociated E18 rat hippocampal neurons with short hairpin plasmid against P19 (shP19-GFP) and observed a distinct loss of staining in transfected cells versus nontransfected cells ( Figure   1b ). A sh-plasmid containing a random hairpin was used as a control and did not diminish P19 staining. Overall, our NEEP21 and P19 antibodies are specific to their respective targets.
| NEEP21 and P19 are similarly expressed in the hippocampus throughout development, but not uniformly in all regions
Given that NEEP21 and P19 are in the same family, we hypothesized that they would be similarly expressed. Indeed, NEEP21 and P19 are both expressed in the hippocampus throughout development (Figures 2 and 3 ). We did not observe any differences along the rostral-caudal axis in the neocortex (not shown) and are showing equivalent sections for all ages and markers. NEEP21 and P19 are present in CTIP2-positive, SatB2-positive, and CTIP2/SatB2-double positive hippocampal neurons in vitro (Digilio et al., 2015) . Similarly, NEEP21 and Unfortunately, anti-Prox1 antibodies did not produce convincing staining on cryosections.
3.3 | NEEP21 and P19 are differentially expressed in the embryonic neocortex
Given the similar NEEP21 and P19 expression in the hippocampus, we hypothesized that they would be expressed in similar spatial and temporal patterns in the developing neocortex. NEEP21 and P19 are both highly expressed in the cortical plate at E17.5 ( Figure 5) . However, many different cell types reside within the cortical plate, so we asked which cells expressed NEEP21 and P19. In particular, we focused on 3.4 | NEEP21 and P19 remain enriched in layer V neurons in the neocortex during development
Clearly, NEEP21 and P19 are both highly expressed throughout the cortical plate during embryonic development ( Figure 5 ). However, previous immunoblot studies have shown that expression levels of NEEP21 in the rat neocortex dramatically decrease postnatally (Steiner et al., 2002 ). Therefore, we tested whether the entire neocortex loses expression of NEEP21 and P19 during development or if the expression levels simply became restricted to certain cell types. We examined NEEP21 and P19 immunohistochemistry in the mouse neocortex through development using CTIP2 as a marker for deeper layer neurons and SatB2 as a marker of neurons in the superficial layers. Already by P8, NEEP21 and P19 expression levels were lower than they were in the P0 brain in a majority of neurons (Figures 8 and 9) . Indeed, by P16 NEEP21 and P19 were expressed at low levels in all neurons in the neocortex but maintained high expression in layer V neurons.
These neurons expressed CTIP2 or Satb2, and this expression is FIG URE 2 NEEP21 is expressed throughout the hippocampus during development. NEEP21 is highly expressed in CA1-CA3 regions of the hippocampus, but less highly expressed in the dentate gyrus (DG). CA1-CA2 and DG are marked by CTIP2, with CA3 showing characteristic lack of CTIP2 consistent along the rostral caudal axis of the neocortex. This shows that higher NEEP21 and P19 levels are maintained in a subpopulation of cortical neurons at later ages, as opposed to a general reduction in protein levels.
| NEEP21 and P19 are expressed in some sets of interneurons in the neocortex
In vitro, we have seen that NEEP21 and P19 are both present in interneuron populations as well as subcortical projection neurons (Digilio et al., 2015) . While we were unable to detect convincing staining using anti-GAD65 antibodies on tissue sections, we asked whether or not we could detect NEEP21 and P19 expression in other subsets of inter- 
| NEEP21 becomes restricted to Purkinje cells during cerebellar development
The cerebellum develops at a later time point than the neocortex, with much of it developing postnatally. Therefore, we stained mid-sagittal sections of cerebellum against NEEP21 in early development (at P0), mid-development (at P8) and fully developed (at P60). Initially, NEEP21 
| DISCUSSION
In this work, we analyzed the protein expression levels of the related family members NEEP21/Nsg1 and P19/Nsg2 in developing mouse brain between E17 and P16. Initial papers describing NEEP21 and P19 expression levels described the two proteins as developmentally regulated. However, the spatial aspects of these changes were not explored and many questions were left unanswered including: Do expression levels decrease across the brain as a whole? Does expression become restricted? Do all neurons lose expression of these two protein? Here, we set out to answer these questions. We showed that NEEP21 and P19 are expressed in distinct spatial and temporal patterns that differ according to brain region by identifying two unexpected aspects of how the NEEP21 and P19 expression profiles change in time and
space. First, we show that both proteins are expressed broadly in all brain regions early in development and then become more restricted in FIG URE 5 Expression patterns of NEEP21 and P19 in the mouse embryonic cortical plate. NEEP21 and P19 are both expressed at high levels in the cortical plate (CP) at E17.5, as marked by SatB2-and CTIP2-positive neurons. CTIP2 marks layer V strongly and layer VI weakly at this age. NEEP21 is also highly expressed in the subplate (SP). P19 is expressed throughout the developing neocortex, and highly in the subventricular zone (SVZ) where NEEP21 is expressed at a much lower level their expression at older ages. Contrary to previous reports, expression does not completely disappear but instead is simply reduced in most neurons while a subset of neurons retain expression. In particular, both NEEP21 and P19 remain expressed in layer V of the neocortex and in CA1 and CA3 of the hippocampus. The second conclusion is that there are some cell types where only one of the two proteins is expressed.
P19 is expressed in the progenitor cells of the subventricular zone whereas NEEP21 is not expressed in this region. NEEP21, on the other hand, retains high expression in Purkinje neurons in P60 cerebellum whereas P19 is strikingly absent from the adult cerebellum. Our findings are summarized in Table 2 .
4.1 | NEEP21 and P19 are expressed highly in CA1 and CA3, but not in dentate gyrus throughout development.
We showed that in the hippocampus, NEEP21 and P19 are widely expressed in the pyramidal cells of the CA1-3 regions with expression remaining high throughout development. This is consistent with the published role of NEEP21 in hippocampal LTP Steiner et al., 2005) . The hippocampus is well known as a brain region responsible for learning and memory. These processes are dependent on the induction of long term depression (LTD) and long term potentiation (LTP) (Malenka & Bear, 2004; Sweatt, 2016) . In LTP, AMPA receptors are recruited to the synapse and inserted into the membrane (Jurado, 2014; MacDougall & Fine, 2014) . At the molecular level, NEEP21 has been shown to facilitate recycling of the AMPAR subunit GluR2 in hippocampal slices, and reduction of NEEP21 levels leads to a decrease in the surface levels of GluR2 containing synapses . Interestingly, the two proteins were relatively less abundant in the granule cells of the DG. This observation agrees with expression of NEEP21 and P19 in hippocampal cultures (Digilio et al., 2015) , and perhaps suggests a differential need for endosomal transport in CA1 and CA3 neurons versus DG neurons. One explanation for this is the anatomy of each hippocampal region. Pyramidal cells make up the majority of the CA1-3 regions of the hippocampus (Dale et al., 2015) and maintain extensive axons and dendritic arbors, while the DG is composed mainly of small granule neurons. We speculate that these large neurons might require specific neuronal endosomal regulators more than smaller, less expansive granule neurons do.
4.2 | NEEP21 and P19 expression is broad during development but persists into adulthood only in a subset of neuronal cell types with large dendritic arbors 4.3 | NEEP21 and P19 are largely co-expressed, but certain cell types express only one of the two proteins Interestingly, NEEP21 and P19 expression patterns were not identical.
NEEP21 and P19 are closely related family members, and we hypothesized that they would have the same expression pattern. This was true in culture (Digilio et al., 2015) as well as for most neurons in situ. However, there were a number of striking exceptions. For instance, the expression patterns diverged early in development (E17 neocortex). At this point during cortical development, P19 was highly expressed in the progenitor layers including the SVZ, which is well known for its role in neurogenesis, while NEEP21 was mainly restricted to the cortical plate.
Radial glia reside in the VZ and can generate neurons and glia, whereas intermediate progenitor cells (IPCs) reside in the SVZ and produce only neurons (Englund et al., 2005; Miyata, Kawaguchi, Okano, & Ogawa, 2001; Noctor, Flint, Weissman, Dammerman, & Kriegstein, 2001; Paridaen & Huttner, 2014) . IPCs express the transcription factor Tbr2, which is down-regulated once the cell's neurogenic fate is determined (Englund et al., 2005; Ochiai et al., 2009 ). Interestingly, P19 was expressed in a subset of Tbr2 positive cells in the SVZ (Figure 7b ). Whereas in the neocortex, NEEP21 and P19 had different expression patterns during development but eventually restricted similarly to layer V (Figures 8 and 9 ), they did not have overlapping expression patterns at any point during development in the cerebellum (Figures 11   and 12 ). P19 was expressed at low levels in many different cell types in the cerebellum at P0 whereas NEEP21 was expressed at a much higher levels. By P8, NEEP21 had overwhelmingly restricted expression to Purkinje cells, whereas P19 levels were low in Purkinje cells and higher in the migrating external granule layer. By P60, P19 was undetectable in the cerebellum, but NEEP21 levels remained high in Purkinje cells.
This suggests non-overlapping roles for NEEP21 and P19 in the FIG URE 8 NEEP21 expression remains enriched in layer V cortical neurons during development. NEEP21 is highly and broadly expressed throughout the cortical plate at P0, but is downregulated overall at P8 and P14, but remains relatively enriched in layer V cerebellum, and specifically in Purkinje cells which maintain a high expression of NEEP21 even after development has completed.
Restriction of protein expression during development was also observed in the third Nsg family member, Calcyon (Caly). Caly was more highly expressed in younger rats as opposed to adult rats, similar to the reduction in NEEP21 and P19 protein levels (Heijtz, Alexeyenko, & Castellanos, 2007) . This points to a key role in brain development for the Nsg family of proteins, and perhaps a continued requirement for these family members in a subset of large adult neurons. We were not able to carry out more detailed comparisons with Caly since the available antibodies do not recognize mouse Caly.
4.4 | Layer V cortical and Purkinje neurons -special needs for endosomal trafficking?
NEEP21 and P19 are both neuronal-enriched endosomal proteins.
From their expression patterns, we can infer that they are important during development of the neocortex, hippocampus, and cerebellum.
Consistent with this observation, we previously showed that FIG URE 9 P19 expression remains enriched in layer V cortical neurons during development. P19 is also broadly expressed in the P0 neocortex. Similarly, to NEEP21, P19 is downregulated overall at P8 and P14, but remains relatively enriched in layer V NEEP21 regulates recycling pathways of the cell adhesion molecule L1. Other developmentally important guidance receptors might also be regulated by NEEP21 and this might explain why most neurons express Nsg family proteins developmentally. We have previously observed dendrite and axon growth defects in cultured neurons grown on L1 substrate when NEEP21 is knocked down, consistent with a role in process elaboration during development (Lasiecka, 2014) .
In addition to high expression universally during development, NEEP21 remains enriched in distinct areas of the brain, including layer V cortical neurons, the CA1-3 region of the hippocampus, and
Purkinje cells in the cerebellum. Considering the complex 
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